West Pharmaceutical Services Inc (WST) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
West Pharmaceutical Services Inc   (NYSE: WST)


West Pharmaceutical Services Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is West Pharmaceutical Services Inc's ROI in the third quarter of 2026?
West Pharmaceutical Services Inc achieved a return on average invested assets (ROI) of 18.19 % in its third quarter of 2026, this is above WST's average return on investment of 13.76%.
West Pharmaceutical Services Inc s investments during the 12 months ending in the third quarter of 2026 are valued at $3 billion

ROI has improved compared to 15.87% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 71 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 501 to 502.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 6.14 % 12.1 % 18.91 % 19.2 % 12.69 %
Y / Y Net Income Change TTM 29.94 % 15.83 % 52.49 % 85.53 % 261.54 %
Investment (TTM) in Millions 3,416 3,436 3,530 3,668 3,604
Return On Investment (TTM) 18.19 % 15.87 % 15.22 % 14.19 % 14.86 %
WST's Overall Ranking # 502 # 501 # 456 # 46 #
Seq. Investment Change TTM -1.31 % -0.19 % 2.51 % 5.12 % 4.23 %
Seq. Net Income Change TTM 13.1 % 4.09 % 9.93 % 0.41 % 0.82 %
Net Income (TTM) in Millions 639 565 543 494 492

WST Company Profile >> Back to WST Roi Comparisons >> See Annual WST Return On Investment



Return On Investment WST's Ranking
Within: No.
Industry # 16
Sector # 72
Overall # 502

Return On Investment Statistics
High Average Low
26.42 %
13.76 %
5.54 %
(Dec 31 2021)   (Sep 30 2011)







Financial Statements
West Pharmaceutical Services Inc's III. Quarter Investments $ 3,416 Millions WST's Balance sheet
West Pharmaceutical Services Inc's III. Quarter Income $ 214 Millions Quarterly WST's Income Statement
WST's Income by Division See WST's Income by Division


WST Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 3,497 2,991 3,061 2,991 2,652
Y / Y Investment Growth 16.91 % -2.28 % 2.34 % 12.77 % 19.47 %
Net Income in Millions 494 493 593 586 662
Y / Y Net Income Growth 0.2 % -16.97 % 1.28 % -11.47 % 91.16 %
Annual Return On Investment 14.12 % 16.47 % 19.39 % 19.59 % 24.96 %


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 14.12 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
WST's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for WST's Competitors
Subscribers only: Roi for West Pharmaceutical Services Inc's Suppliers
Subscribers only: Return On Investment for WST's Customers

Other Ratios
WST's Roa WST's Inventory Turnover Ratio WST's Growth Rates WST's Dividend Statistics
WST's Profitability Ratios WST's Asset Turnover Ratio WST's Dividend Growth
WST's Roe WST's Valuation Ratios WST's Financial Strength Ratios WST's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Aurinia Pharmaceuticals Inc   45.04 %
Nurix Therapeutics Inc   44.12 %
Medpace Holdings Inc   41.14 %
Rallybio Corporation  36.04 %
Eli Lilly And Company  32.00 %
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Acadia Pharmaceuticals Inc   26.89 %
Protalix Biotherapeutics inc   26.06 %
Standard Biotools Inc   23.91 %
Electromed Inc   23.41 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %

Date modified: 2026-10-30T16:58:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.